A translocation involving the placental growth factor gene is identified in an epithelioid hemangioendothelioma

Cancer Genetics and Cytogenetics

Volumn 168, Issue 2, 2006, Pages 150-154

  He, Mai ^a   Das, Kasturi ^a   Blacksin, Marcia ^a   Benevenia, Joseph ^a   Hameed, Meera ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACENTAL GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT; ANGIOGENESIS; ARTICLE; BINDING AFFINITY; CARCINOGENESIS; CASE REPORT; CHROMOSOME 10P; CHROMOSOME 14Q; CHROMOSOME TRANSLOCATION 10; CHROMOSOME TRANSLOCATION 14; FEMALE; FOLLOW UP; FOOT; GENE EXPRESSION; GENE IDENTIFICATION; GENE TRANSLOCATION; GROWTH REGULATION; HEMANGIOENDOTHELIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING;

CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 14; FEMALE; FOOT DISEASES; HEMANGIOENDOTHELIOMA, EPITHELIOID; HUMANS; MIDDLE AGED; PREGNANCY PROTEINS; TRANSLOCATION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR NEOPLASMS;

EID: 33745683768     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.02.010     Document Type: Article

References (23)

1. Mendlick M.R., Nelson M., Pickering D., Johansson S.L., Seemayer T.A., Neff J.R., Vergara G., Rosenthal H., and Bridge J.A. Translocation t(1;3)(p36.3;q25) is a nonrandom aberration in epithelioid hemangioendothelioma. Am J Surg Pathol 25 (2001) 684-687
2. Boudousquie A.C., Lawce H.J., Sherman R., Olson S., Magenis R.E., and Corless C.L. Complex translocation [7;22] identified in an epithelioid hemangioendothelioma. Cancer Genet Cytogenet 92 (1996) 116-121
3. Ingraham S.E., Lynch R.A., Kathiresan S., Buckler A.J., and Menon A.G. hREC2, a RAD51-like gene, is disrupted by t(12;14)(q15;q24.1) in a uterine leiomyoma. Cancer Genet Cytogenet 115 (1999) 56-61
4. Blank C., Schoenmakers E.F., Rogalla P., Huys E.H., van Rijk A.A., Drieschner N., and Bullerdiek J. Intragenic breakpoint within RAD51L1 in a t(6;14)(p21.3;q24) of a pulmonary chondroid hamartoma. Cytogenet Cell Genet 95 (2001) 17-19
5. Maglione D., Guerriero V., Viglietto G., Delli-Bovi P., and Persico M.G. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88 (1991) 9267-9271
6. Maglione D., Guerriero V., Viglietto G., Ferraro M.G., Aprelikova O., Alitalo K., Del Vecchio S., Lei K.J., Chou J.Y., and Persico M.G. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene 8 (1993) 925-931
7. Hauser S., and Weich H.A. A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors 9 (1993) 259-268
8. Khaliq A., Li X.F., Shams M., Sisi P., Acevedo C.A., Whittle M.J., Weich H., and Ahmed A. Localisation of placenta growth factor (PlGF) in human term placenta. Growth Factors 13 (1996) 243-250
9. Vuorela P., Hatva E., Lymboussaki A., Kaipainen A., Joukov V., Persico M.G., Alitalo K., and Halmesmaki E. Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod 56 (1997) 489-494
10. Takahashi A., Sasaki H., Kim S.J., Tobisu K., Kakizoe T., Tsukamoto T., Kumamoto Y., Sugimura T., and Terada M. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res 54 (1994) 4233-4237
11. Park J.E., Chen H.H., Winer J., Houck K.A., and Ferrara N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 69 (1994) 25646-25654
12. DiSalvo J., Bayne M.L., Conn G., Kwok P.W., Trivedi P.G., Soderman D.D., Palisi T.M., Sullivan K.A., and Thomas K.A. Purification and characterization of a naturally occurring vascular endothelial growth factor.placenta growth factor heterodimer. J Biol Chem 270 (1995) 7717-7723
13. Cao Yihai, Chen Hua, Zhou Li, Chiang Ming-Ko, Anand-Apte Bela, Weatherbee James A, Wang Yongda, Fang Faye, Flanagan John G, Tsang Monica Lik-Shing. Heterodimers of placenta growth factor/vascular endothelial growth factor. J Biol Chem 1996;271:3154-62.
14. Autiero M., Waltenberger J., Communi D., Kranz A., Moons L., Lambrechts D., Kroll J., Plaisance S., De Mol M., Bono F., Kliche S., Fellbrich G., Ballmer-Hofer K., Maglione D., Mayr-Beyrle U., Dewerchin M., Dombrowski S., Stanimirovic D., Van Hummelen P., Dehio C., Hicklin D.J., Persico G., Herbert J.M., Communi D., Shibuya M., Collen D., Conway E.M., and Carmeliet P. Role of PlGF in the intra- and intermolecular cross-talk between the VEGF receptors Flt1 and Flk1. Nat Med 9 (2003) 936-943
15. Bohling T., Hatva E., Kujala M., Claesson-Welsh L., Alitalo K., and Haltia M. Expression of growth factors and growth factor receptors in capillary hemangioblastoma. J Neuropathol Exp Neurol 55 (1996) 522-527
16. Dyduch G., Okon K., and Mierzynski W. Benign vascular proliferations-an immunohistochemical and comparative study. Pol J Pathol 55 (2004) 59-64
17. Taege C., Holzhausen H., Gunter G., Flemming P., Rodeck B., and Rath F.W. Malignant epithelioid hemangioendothelioma of the liver - a very rare tumor in children. Pathologe 20 (1999) 345-350
18. Theurillat J.P., Vavricka S.R., Went P., Weishaupt D., Perren A., Leonard-Meier C., and Bachli E.B. Morphologic changes and altered gene expression in an epithelioid hemangioendothelioma during a ten-year course of disease. Pathol Res Pract 199 (2003) 165-170
19. Szymik-Kantorowicz S., Partyka L., Dembinska-Kiec A., and Zdzienicka A. Vascular endothelial growth factor in monitoring therapy of hepatic haemangioendothelioma. Med Pediatr Oncol 40 (2003) 196-197 (no abstract available)
20. Miller M.A., and Sandler A.D. Elevated plasma vascular endothelial growth factor levels in 2 patients with hemangioendothelioma. J Pediatr Surg 40 (2005) 17-19
21. Ilan N., Tucker A., and Madri J.A. Vascular endothelial growth factor expression, beta-catenin tyrosine phosphorylation, and endothelial proliferative behavior: a pathway for transformation?. Lab Invest 83 (2003) 1105-1115
22. Ito H., Yamasaki T., Okamoto O., and Tahara E. Infantile hemangioendothelioma of the liver in patient with interstitial deletion of chromosome 6q: report of an autopsy case. Am J Med Genet 34 (1989) 325-329
23. Presta L.G., Chen H., O'Connor S.J., Chisholm V., Meng Y.G., Krummen L., Winkler M., and Ferrara N. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res 57 (1997) 4593-4599